En SOLTI despedimos este 2025 por todo lo alto 🥂 ¿Cómo ha sido nuestro mes de diciembre?

✅ The wait is over: BITES 6 is LIVE: "HER2-Positive breast cancer: updates on biomarkers and treatment strategies from 2025 onward".   🔗 https://www.scientificbites.com/register/usuario/?lang=en

Only 3 days! BITES 6 launches 22.12 🗓 #ScientificBites is a free, open-access e-learning platform designed to bring you the latest updates and breakthroughs in clinical and translational cancer research quickly, clearly, and innovatively. 🔗 https://www.scientificbites.com/register/usuario/?lang=en

Fueron muchos los momentos y las personas que nos ayudaron a escribir, por primera vez, la historia de SOLTI.  30 años concentrados en 45 minutos y un lema “Si SOLTI dice ven”. Descubre una historia llena de ciencia, valentía y emoción 🎬🧬✨ 🔗 https://youtu.be/PSvsFldXunU?si=_-QQ7PZhA5ByRtx4 #beSOLTI

📣 ¡inscríbete en la 2ª edición del SOLTI Young – Development Program! Formato online y presencial, ponentes nacionales e internacionales, meet the expert, discusión de casos clínicos, workshops y debates. Plazas limitadas 🔗 Inscripciones: https://www.gruposolti.org/events/developmentprogram2026/

🎬 Countdown to BITES VI premiering December 22! An innovative e-learning initiative by SOLTI, #ScientificBites brings forward-thinking online modules on the most cutting-edge topics in breast cancer, guided by leading international specialists. Learn more at 🔗 https://www.scientificbites.com/

🧬 El ensayo internacional DESTINY-Breast05 demuestra que trastuzumab deruxtecán reduce a la mitad el riesgo de recaída invasiva en pacientes con cáncer de mama HER2 positivo temprano que presentan enfermedad residual tras el tratamiento neoadyuvante.

¿Sabías que tus pacientes pueden acceder al estudio HOPE-Focus para realizar un análisis de sangre y tejido tumoral y así obtener información molecular detallada?  👉 Más info y formulario de inscripción en 🔗 www.hopefocus.es  #beSOLTI #HOPEFocus #cáncerdemama

SOLTI team is leaving #SABCS25 full of new ideas, insights, and renewed energy to keep advancing breast cancer research. A huge thank you to all the organizers, speakers, and colleagues. 📸 Here we are, celebrating a week full of learning, and shared knowledge! See you in 2026 🙌 #beSOLTI

Our last #SYPerspectives highlight is delivered by Alexandra Garcilazo, MD. Our speaker reviews the latest updates on TNBC presented at #SABCS25. 📹 View the complete video here: www.youtube.com/watch?v=EESw... 🤝Supported by a grant from @daiichisankyo.bsky.social #beSOLTI #SOLTIYoung

Just presented, at #SABCS25 results of RADIOLA, a study that provides new evidence on the value of the RAD51 functional test for optimizing patient selection in HER2- metastatic breast cancer treated with olaparib. Dr.Isabel Pimentel. #beSOLTI #SABCS25 @prat-aleix-md.bsky.social @vhio.bsky.social

During #SABCS25: interim results of the ACROSS-TROP2 study, a SOLTI-led phase II trial investigating biomarkers of response and resistance to Sacituzumab Govitecan in advanced HR+/HER2- #breastcancer, led by Dr. Eva Ciruelos and Dr. @moliveira-md.bsky.social #beSOLTI @vhio.bsky.social

At #SABCS25, we presented results from the PremiÈRe study (SOLTI-2104), the first trial to evaluate the use of the oral drug elacestrant in premenopausal women with early HR+/HER2- BC, led by Meritxell Bellet,MD 📄Read the full press release here: www.gruposolti.org/the-premiere... #beSOLTI

Carla Gullotta, MD, Medical Oncology resident and SOLTI Young fellow, explains us her two posters presented in Poster Session 2&3 at #SABCS25. 📹 Here you can access the complete video: youtu.be/yvbNpXKFKmM 🤝 Supported by @daiichisankyo.bsky.social #beSOLTI #SYPerspectives #SOLTIYoung

In this new video of #SYPerspectives, Benedetta Conte delivers updates on advanced luminal BC from #SABCS25 📹 youtu.be/AmnCX-TcEso Subscribe now to our newsletter: www.gruposolti.org/solti-young-... 🤝 This project is supported by a grant from @daiichisankyo.bsky.social #beSOLTI #SOLTIYoung

Benjamin Walbaum,MD discusses the results from the lidERA trial presented in GS1 at #SABCS25. 📹Watch the complete video of #SYPerspectives here: youtu.be/_F9gATNIrBo 🤝 Supported by a grant from @daiichisankyo.bsky.social #beSOLTI #SABCS25

Elia Seguí MD shares with us interesting data on translational research from GS2 at #SABCS25 📹 youtu.be/xfbTG8JbVME Stay tuned #SYPerspectives! Subscribe here 🔗 www.gruposolti.org/solti-young-... 🤝 This project is supported by a grant from @daiichisankyo.bsky.social #beSOLTI #SOLTIYoung

Right after GS1 at #SABCS25, Rodrigo Sanchez Bayona gives us the latest insights on advanced HER2+BC. Find the full video on YouTube! youtu.be/Oh5Dz4ExakU Join us!🔗 www.gruposolti.org/solti-young-... 🤝 Supported by a grant from @daiichisankyo.bsky.social #beSOLTI #SOLTIYoung

As part of #SYPerspectives, Carla Gullotta shares the latest updates on Early HER2+ BC, just after GS1 at #SABCS25. 🎥 Watch the full video here: youtu.be/nRpudtK9McY Subscribe to our newsletter! www.gruposolti.org/solti-young-... 🤝 Supported by a grant from @daiichisankyo.bsky.social #beSOLTI

Busy schedule full of meetings and sessions? If you miss something, don't worry: #SYPerspectives will deliver you #SABCS25 highlights. Today, we have been warming up, take a look! ⬇️ 📩 Subscribe now www.gruposolti.org/solti-young-... 🤝Supported by a grant from @daiichisankyo.bsky.social #beSOLTI

We’re in #SABCS25 where the global scientific puzzle begins to come together. In the next few days, we’ll dive into data years in the making and explore insights that could reshape clinical practice and impact countless patients. Stay tuned for updates from inside #SABCS25! 🙌 #beSOLTI

1 Day to go...  @sabcs.bsky.social . Discover the SOLTI Young Fellows al SABCS: Dr. Carla Gullotta shares updates on early HER2+ breast cancer & her two posters. Agustín Sánchez, PhD Candidate, highlights key AI posters in breast cancer research. #beSOLTI #SYPerspectives #SOLTIYoung #SABCS25

Benedetta Conte joins us for SOLTI Young Perspectives at @sabcs.bsky.social 🔬 She’ll share key insights in advanced luminal breast cancer, closing the line-up of our three international speakers. 📩  #SYPerspectives #SOLTIYoung #SABCS25

Meet Alexandra Garcilazo, Medical Oncologist at Instituto Nacional de Cancerología (Mexico) and one of our international speakers for #SYPersepectives at  @sabcs.bsky.social  ! 🧬 She’ll share the latest updates on triple-negative breast cancer. #SYPerspectives #SOLTIYoung #SABCS25

We continue introducing our #SYPerspectives speakers at @sabcs.bsky.social . Benjamin Walbaum, MD, Medical Oncologist at Hospital Clínico Universidad Católica de Chile and member of SOLTI Young, is another one of our international speakers. He’ll share updates on early luminal breast cancer #SABCS25

Discover our experts for #SYPerspectives at  @sabcs.bsky.social  Rodrigo Sánchez-Bayona, MD, PhD (Hospital 12 de Octubre; member of the SOLTI Young Coordinating Committee) will bring the latest on advanced HER2+ breast cancer. #beSOLTI #SYPerspectives #SOLTIYoung #SABCS25

📣 Exciting news #SOLTIYoung will be at @sabcs.bsky.social  with SY Perspectives! Meet Elia Seguí MD, Dana-Farber Cancer Institute; member of the SOLTI Young Coordinating Committee, who will be presenting the latest updates on translational research 🧬 🤝 #SYPerspectives #SABCS25

Ya está disponible la publicación de SOLTI -PATRICIA cohort C en Clinical Cancer Research, un paso importante hacia tratamientos más personalizados para las pacientes con cáncer de mama metastásico HER2+/HR+.

👋 ¡Ya estamos por aquí también! y empezamos con noticias 📰👇